CELGENE CORP Business Finance Contracts & Agreements

47 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Assignment, Assumption and Amendment Agreement, dated as of November 20, 2019, among Bristol-Myers Squibb Company, Celgene Corporation, American Stock Transfer & Trust Company,...
Stock Agreements
CELGENE CORP
Pharmaceuticals
NY
2019
Asset Purchase Agreement dated August 25, 2019, by and between Celgene Corporation, as seller, and Amgen Inc., as purchaser
Purchase Agreements
CELGENE CORP
Pharmaceuticals
NY
2019
First Supplemental Indenture, dated May 1, 2019, to Indenture, dated February 20, 2018 by and between Celgene Corporation, as Issuer, and The Bank of New York Mellon Trust...
Indenture Agreements
CELGENE CORP
Pharmaceuticals
NY
2019
First Supplemental Indenture, dated May 1, 2019, to Indenture, dated November 9, 2017 by and between Celgene Corporation, as Issuer, and The Bank of New York Mellon Trust Company,...
Indenture Agreements
CELGENE CORP
Pharmaceuticals
NY
2019
First Supplemental Indenture, dated May 1, 2019, to Indenture, dated August 10, 2017 by and between Celgene Corporation, as Issuer, and The Bank of New York Mellon Trust Company,...
Indenture Agreements
CELGENE CORP
Pharmaceuticals
NY
2019
First Supplemental Indenture, dated May 1, 2019, to Indenture, dated August 12, 2015 by and between Celgene Corporation, as Issuer, and The Bank of New York Mellon Trust Company,...
Indenture Agreements
CELGENE CORP
Pharmaceuticals
NY
2019
First Supplemental Indenture, dated May 1, 2019, to Indenture, dated May 15, 2014 by and between Celgene Corporation, as Issuer, and The Bank of New York Mellon Trust Company,...
Indenture Agreements
CELGENE CORP
Pharmaceuticals
NY
2019
First Supplemental Indenture, dated May 1, 2019, to Indenture, dated August 6, 2013 by and between Celgene Corporation, as Issuer, and The Bank of New York Mellon Trust Company,...
Indenture Agreements
CELGENE CORP
Pharmaceuticals
NY
2019
First Supplemental Indenture, dated May 1, 2019, to Indenture, dated August 9, 2012 by and between Celgene Corporation, as Issuer, and The Bank of New York Mellon Trust Company,...
Indenture Agreements
CELGENE CORP
Pharmaceuticals
NY
2019
First Supplemental Indenture, dated May 1, 2019, to Indenture, dated October 7, 2010 by and between Celgene Corporation, as Issuer, and The Bank of New York Mellon Trust Company,...
Indenture Agreements
CELGENE CORP
Pharmaceuticals
NY
2019
Amended and Restated Credit Agreement, dated as of April 25, 2018
Credit Agreements
CELGENE CORP
Pharmaceuticals
DE
2018
Form of 4.550% Senior Note due 2048
Note Agreements
CELGENE CORP
Pharmaceuticals
NY
2018
Form of 3.900% Senior Note due 2028
Note Agreements
CELGENE CORP
Pharmaceuticals
NY
2018
Form of 3.250% Senior Note due 2023
Note Agreements
CELGENE CORP
Pharmaceuticals
NY
2018
Form of 2.875% Senior Note due 2021
Note Agreements
CELGENE CORP
Pharmaceuticals
NY
2018
Indenture, dated as of February 20, 2018, relating to the 2.875% Senior Notes due 2021, the 3.250% Senior Notes due 2023, the 3.900% Senior Notes due 2028 and the 4.550% Senior...
Indenture Agreements
CELGENE CORP
Pharmaceuticals
NY
2018
Underwriting Agreement, dated as of February 8, 2018, among the Company and Citigroup Global Markets Inc., Deutsche Bank Securities Inc., J.P. Morgan Securities LLC and Merrill...
Underwriting Agreements
CELGENE CORP
Pharmaceuticals
NY
2018
Form of 4.350% Senior Note due 2047
Note Agreements
CELGENE CORP
Pharmaceuticals
NY
2017
Form of 3.450% Senior Note due 2027
Note Agreements
CELGENE CORP
Pharmaceuticals
NY
2017
Form of 2.750% Senior Note due 2023
Note Agreements
CELGENE CORP
Pharmaceuticals
NY
2017
Indenture, dated as of November 9, 2017, relating to the 2.750% Senior Notes due 2023, the 3.450% Senior Notes due 2027 and the 4.350% Senior Notes due 2047 between the Company...
Indenture Agreements
CELGENE CORP
Pharmaceuticals
NY
2017
Underwriting Agreement, dated as of October 31, 2017, among the Company and Barclays Capital Inc., Credit Suisse Securities (USA) LLC, Goldman Sachs & Co. LLC, J.P. Morgan...
Underwriting Agreements
CELGENE CORP
Pharmaceuticals
NY
2017
Form of 5.000% Senior Note due 2045 GLOBAL SECURITY
Note Agreements
CELGENE CORP
Pharmaceuticals
NY
2015
Form of 3.875% Senior Note due 2025 GLOBAL SECURITY
Note Agreements
CELGENE CORP
Pharmaceuticals
NY
2015
Form of 3.550% Senior Note due 2022 GLOBAL SECURITY
Note Agreements
CELGENE CORP
Pharmaceuticals
NY
2015
Form of 2.875% Senior Note due 2020 GLOBAL SECURITY
Note Agreements
CELGENE CORP
Pharmaceuticals
NY
2015
Form of 2.125% Senior Note due 2018 GLOBAL SECURITY
Note Agreements
CELGENE CORP
Pharmaceuticals
NY
2015
CELGENE CORPORATION, as Issuer, and TheBank of New York Mellon Trust Company, N.A., as Trustee INDENTURE Dated as of August 12, 2015
Indenture Agreements
CELGENE CORP
Pharmaceuticals
NY
2015
CELGENE CORPORATION $1,000,000,000 2.125% SENIOR NOTESDUE 2018 $1,500,000,000 2.875% SENIOR NOTESDUE 2020 $1,000,000,000 3.550% SENIOR NOTESDUE 2022 $2,500,000,000 3.875% SENIOR...
Underwriting Agreements
CELGENE CORP
Pharmaceuticals
NY
2015
U.S. $1,750,000,000 SECOND AMENDED AND RESTATED CREDIT AGREEMENT Dated as of April 17, 2015 Among CELGENE CORPORATION as Borrower and THE INITIAL LENDERS NAMED HEREIN as Initial...
Credit Agreements
CELGENE CORP
Pharmaceuticals
DE
2015
Form of 4.625% Senior Note due 2044 GLOBAL SECURITY
Note Agreements
CELGENE CORP
Pharmaceuticals
NY
2014
Form of 3.625% Senior Note due 2024 GLOBAL SECURITY
Note Agreements
CELGENE CORP
Pharmaceuticals
NY
2014
Form of 2.250% Senior Note due 2019 GLOBAL SECURITY
Note Agreements
CELGENE CORP
Pharmaceuticals
NY
2014
CELGENECORPORATION, as Issuer, and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee INDENTURE Dated as of May 15, 2014
Indenture Agreements
CELGENE CORP
Pharmaceuticals
NY
2014
CELGENE CORPORATION $500,000,000 2.250% SENIOR NOTES DUE 2019 $1,000,000,000 3.625% SENIOR NOTES DUE 2024 $1,000,000,000 4.625% SENIOR NOTES DUE 2044 UNDERWRITING AGREEMENT May 6,...
Underwriting Agreements
CELGENE CORP
Pharmaceuticals
NY
2014
Form of 5.250% Senior Note due 2043 GLOBAL SECURITY
Note Agreements
CELGENE CORP
Pharmaceuticals
NY
2013
Form of 4.000% Senior Note due 2023 GLOBAL SECURITY
Note Agreements
CELGENE CORP
Pharmaceuticals
NY
2013
Form of 2.300% Senior Note due 2018 GLOBAL SECURITY
Note Agreements
CELGENE CORP
Pharmaceuticals
NY
2013
CELGENE CORPORATION, as Issuer, and THE BANK OFNEW YORK MELLON TRUST COMPANY, N.A., as Trustee INDENTURE Dated as of August 6, 2013 CROSS-REFERENCE TABLE
Indenture Agreements
CELGENE CORP
Pharmaceuticals
NY
2013
CELGENE CORPORATION $400,000,000 2.300% SENIOR NOTES DUE 2018 $700,000,000 4.000% SENIOR NOTES DUE 2023 $400,000,000 5.250% SENIOR NOTES DUE 2043 UNDERWRITING AGREEMENT August 1,...
Underwriting Agreements
CELGENE CORP
Pharmaceuticals
NY
2013